May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Flow Cytometric Analysis of ICAM-1 and HLA-DR Expression in Conjunctival Epithelium Following Allergen Challenge
Author Affiliations & Notes
  • L. Tinios
    Ophthalmic Research Associates, North Andover, MA, United States
  • M. Mroz
    Ophthalmic Research Associates, North Andover, MA, United States
  • P.J. Gomes
    Ophthalmic Research Associates, North Andover, MA, United States
  • M.B. Abelson
    The Schepens Eye Research Institute, Harvard Medical School, Boston, MA, United States
  • Footnotes
    Commercial Relationships  L. Tinios, None; M. Mroz, None; P.J. Gomes, None; M.B. Abelson, None.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 3742. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      L. Tinios, M. Mroz, P.J. Gomes, M.B. Abelson; Flow Cytometric Analysis of ICAM-1 and HLA-DR Expression in Conjunctival Epithelium Following Allergen Challenge . Invest. Ophthalmol. Vis. Sci. 2003;44(13):3742.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Expression of inflammatory cell-markers has previously been shown to increase in response to allergen challenge. The purpose of this study was to determine what happens to expression after 24-hour re-challenge. Methods: Bilateral conjunctival allergen challenge (CAC) was performed the morning of Visit 1 and again 24-hours later at Visit 2. Each subject was challenged using a dose of allergen previously determined to elicit a positive reaction (defined as moderate or greater itching and redness). Impression cytology specimens were collected from neighboring areas of the superotemporal and inferotemporal bulbar conjunctiva at 4 times during the study- 1 hour prior to CAC at Visit 1 (Pre-V1); 45 minutes post CAC at Visit 1 (V1-Post); 1 hour prior to CAC at Visit 2 (Pre-V2); and 45 minutes post CAC at Visit 2 (V2-Post). Cells were processed for flow cytometry using monoclonal antibodies to ICAM-1 and HLA-DR antigens (Beckman Coulter). Percentages of positive cells were calculated and levels of expression quantified after conversion into standardized units of fluorescence (ABC units). Results: The 9 subjects enrolled all exhibited a successful allergic response to challenge. ICAM-1 expression, both in percentage of positive cells and level of expression, was significantly increased at V1-Post and Pre-V2 compared with Pre-V1 levels. ICAM-1 expression at V2-Post returned to near Pre-V1 levels. Mean percentage of ICAM-1 positive cells was 53% at Pre-V1, 67% at V1-Post (P = 0.045), 74% at Pre-V2 (P = 0.014), and 60% at V2-Post (P = 0.136). Mean level of expression of ICAM-1 was 393 ABCs at Pre-V1, 895 at V1-Post (P = 0.004), 1104 at Pre-V2 (P = 0.017), and 592 at V2-Post (P = 0.381). HLA-DR expression was similar in trend to that of ICAM-1; however, the changes were not statistically significant. Conclusions: As expected, ICAM-1 expression was significantly upregulated after the first challenge. The fact that expression decreased after re-challenge strongly suggests the presence of some sort of negative feedback mechanism, possibly regulated by mediators from cells in the tissue.

Keywords: conjunctiva • gene/expression 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×